Related Experiment Videos
Invasive group B streptococcal infections in Finland: a population-based study
Outi Lyytikäinen1, J Pekka Nuorti, Erja Halmesmäki
1National Public Health Institute, Helsinki, Finland. outi.lyytikainen@ktl.fi
Emerging Infectious Diseases
|April 19, 2003
Summary
Group B Streptococcus (GBS) infection in Finland shows low incidence but suboptimal prevention. National guidelines are needed to reduce early-onset GBS disease in newborns.
Area of Science:
- Neonatal infections
- Bacterial pathogenesis
- Public health surveillance
Background:
- Group B Streptococcus (GBS) is a leading cause of neonatal infections.
- Early-onset GBS disease poses a significant threat to newborns.
- Finland's GBS surveillance data provides insights into infection trends.
Purpose of the Study:
- To analyze the incidence and trends of GBS infections in Finland from 1995-2000.
- To review neonatal cases of early-onset GBS disease and associated risk factors.
- To evaluate current prevention practices and recommend improvements.
Main Methods:
- Analysis of national surveillance data for GBS cases (1995-2000).
- Review of neonatal GBS infection cases in selected Finnish hospitals (1999-2000).
- Assessment of risk factors and maternal colonization rates.
Main Results:
- 853 GBS cases reported annually (incidence 2.2-3.0/100,000 population).
- 32-38 neonatal early-onset GBS cases per year (incidence 0.6-0.7/1,000 live births).
- 35% of neonatal cases had risk factors; 5/8 mothers screened were colonized; one case occurred despite chemoprophylaxis.
Conclusions:
- Finland has a relatively low incidence of early-onset GBS disease, but geographic variations exist.
- Current prevention strategies for perinatal GBS are suboptimal.
- Implementing national guidelines for GBS prevention is crucial to reduce neonatal disease incidence.